BACKGROUND: In twin pregnancies, the rates of adverse perinatal outcome and subsequent long-term morbidity are substantial, and mainly result from preterm birth (PTB). OBJECTIVES: To assess the effectiveness of progestogen treatment in the prevention of neonatal morbidity or PTB in twin pregnancies using individual participant data meta-analysis (IPDMA). SEARCH STRATEGY: We searched international scientific databases, trial registration websites, and references of identified articles. SELECTION CRITERIA: Randomised clinical trials (RCTs) of 17-hydroxyprogesterone caproate (17Pc) or vaginally administered natural progesterone, compared with placebo or no treatment. DATA COLLECTION AND ANALYSIS: Investigators of identified RCTs were asked to share their IPD. The primary outcome was a composite of perinatal mortality and severe neonatal morbidity. Prespecified subgroup analyses were performed for chorionicity, cervical length, and prior spontaneous PTB. MAIN RESULTS: Thirteen trials included 3768 women and their 7536 babies. Neither 17Pc nor vaginal progesterone reduced the incidence of adverse perinatal outcome (17Pc relative risk, RR 1.1; 95% confidence interval, 95% CI 0.97-1.4, vaginal progesterone RR 0.97; 95% CI 0.77-1.2). In a subgroup of women with a cervical length of ≤25 mm, vaginal progesterone reduced adverse perinatal outcome when cervical length was measured at randomisation (15/56 versus 22/60; RR 0.57; 95% CI 0.47-0.70) or before 24 weeks of gestation (14/52 versus 21/56; RR 0.56; 95% CI 0.42-0.75). AUTHOR'S CONCLUSIONS: In unselected women with an uncomplicated twin gestation, treatment with progestogens (intramuscular 17Pc or vaginal natural progesterone) does not improve perinatal outcome. Vaginal progesterone may be effective in the reduction of adverse perinatal outcome in women with a cervical length of ≤25 mm; however, further research is warranted to confirm this finding.
BACKGROUND: In twin pregnancies, the rates of adverse perinatal outcome and subsequent long-term morbidity are substantial, and mainly result from preterm birth (PTB). OBJECTIVES: To assess the effectiveness of progestogen treatment in the prevention of neonatal morbidity or PTB in twin pregnancies using individual participant data meta-analysis (IPDMA). SEARCH STRATEGY: We searched international scientific databases, trial registration websites, and references of identified articles. SELECTION CRITERIA: Randomised clinical trials (RCTs) of 17-hydroxyprogesterone caproate (17Pc) or vaginally administered natural progesterone, compared with placebo or no treatment. DATA COLLECTION AND ANALYSIS: Investigators of identified RCTs were asked to share their IPD. The primary outcome was a composite of perinatal mortality and severe neonatal morbidity. Prespecified subgroup analyses were performed for chorionicity, cervical length, and prior spontaneous PTB. MAIN RESULTS: Thirteen trials included 3768 women and their 7536 babies. Neither 17Pc nor vaginal progesterone reduced the incidence of adverse perinatal outcome (17Pc relative risk, RR 1.1; 95% confidence interval, 95% CI 0.97-1.4, vaginal progesterone RR 0.97; 95% CI 0.77-1.2). In a subgroup of women with a cervical length of ≤25 mm, vaginal progesterone reduced adverse perinatal outcome when cervical length was measured at randomisation (15/56 versus 22/60; RR 0.57; 95% CI 0.47-0.70) or before 24 weeks of gestation (14/52 versus 21/56; RR 0.56; 95% CI 0.42-0.75). AUTHOR'S CONCLUSIONS: In unselected women with an uncomplicated twin gestation, treatment with progestogens (intramuscular 17Pc or vaginal natural progesterone) does not improve perinatal outcome. Vaginal progesterone may be effective in the reduction of adverse perinatal outcome in women with a cervical length of ≤25 mm; however, further research is warranted to confirm this finding.
Authors: Dwight J Rouse; Steve N Caritis; Alan M Peaceman; Anthony Sciscione; Elizabeth A Thom; Catherine Y Spong; Michael Varner; Fergal Malone; Jay D Iams; Brian M Mercer; John Thorp; Yoram Sorokin; Marshall Carpenter; Julie Lo; Susan Ramin; Margaret Harper; Garland Anderson Journal: N Engl J Med Date: 2007-08-02 Impact factor: 91.245
Authors: Arianne C Lim; Ewoud Schuit; Kitty Bloemenkamp; Rob E Bernardus; Johannes J Duvekot; Jan Jaap H M Erwich; Jim van Eyck; Rolf H H Groenwold; Tom H M Hasaart; Piet Hummel; Michael M Kars; Anneke Kwee; Charlotte M van Oirschot; Mariëlle G van Pampus; Dimitri Papatsonis; Martina M Porath; Marc E Spaanderman; Christine Willekes; Janine Wilpshaar; Ben W J Mol; Hein W Bruinse Journal: Obstet Gynecol Date: 2011-09 Impact factor: 7.661
Authors: Christian M Briery; Edward W Veillon; Chad K Klauser; Rick W Martin; Suneet P Chauhan; Everett F Magann; John C Morrison Journal: South Med J Date: 2009-09 Impact factor: 0.954
Authors: Joyce A Martin; Brady E Hamilton; Stephanie J Ventura; Michelle J K Osterman; Sharon Kirmeyer; T J Mathews; Elizabeth C Wilson Journal: Natl Vital Stat Rep Date: 2011-11-03
Authors: V Serra; A Perales; J Meseguer; J J Parrilla; C Lara; J Bellver; R Grifol; I Alcover; M Sala; J C Martínez-Escoriza; A Pellicer Journal: BJOG Date: 2012-08-13 Impact factor: 6.531
Authors: J M O'Brien; C D Adair; D F Lewis; D R Hall; E A Defranco; S Fusey; P Soma-Pillay; K Porter; H How; R Schackis; D Eller; Y Trivedi; G Vanburen; M Khandelwal; K Trofatter; D Vidyadhari; J Vijayaraghavan; J Weeks; B Dattel; E Newton; C Chazotte; G Valenzuela; P Calda; M Bsharat; G W Creasy Journal: Ultrasound Obstet Gynecol Date: 2007-10 Impact factor: 7.299
Authors: Frances E Likis; Digna R Velez Edwards; Jeffrey C Andrews; Alison L Woodworth; Rebecca N Jerome; Christopher J Fonnesbeck; J Nikki McKoy; Katherine E Hartmann Journal: Obstet Gynecol Date: 2012-10 Impact factor: 7.661
Authors: Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe Journal: N Engl J Med Date: 2003-06-12 Impact factor: 91.245
Authors: Ramkumar Menon; Elizabeth A Bonney; Jennifer Condon; Sam Mesiano; Robert N Taylor Journal: Hum Reprod Update Date: 2016-06-30 Impact factor: 15.610
Authors: C A Combs; E Schuit; S N Caritis; A C Lim; T J Garite; K Maurel; D Rouse; E Thom; A T Tita; Bwj Mol Journal: BJOG Date: 2015-12-10 Impact factor: 6.531
Authors: L N Yelland; E Schuit; J Zamora; P F Middleton; A C Lim; A H Nassar; L Rode; V Serra; E A Thom; C Vayssière; Bwj Mol; S Gates Journal: BJOG Date: 2018-06-25 Impact factor: 6.531